These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


569 related items for PubMed ID: 17120268

  • 1. Design, synthesis and pharmacological evaluation of cyclic mimetics of the insulin-like peptide 3 (INSL3) B-chain.
    Shabanpoor F, Bathgate RA, Hossain MA, Giannakis E, Wade JD, Hughes RA.
    J Pept Sci; 2007 Feb; 13(2):113-20. PubMed ID: 17120268
    [Abstract] [Full Text] [Related]

  • 2. Design and development of analogues of dimers of insulin-like peptide 3 B-chain as high-affinity antagonists of the RXFP2 receptor.
    Shabanpoor F, Zhang S, Hughes RA, Hossain MA, Layfield S, Ferraro T, Bathgate RA, Separovic F, Wade JD.
    Biopolymers; 2011 Feb; 96(1):81-7. PubMed ID: 20560146
    [Abstract] [Full Text] [Related]

  • 3. Role of the intra-A-chain disulfide bond of insulin-like peptide 3 in binding and activation of its receptor, RXFP2.
    Zhang S, Hughes RA, Bathgate RA, Shabanpoor F, Hossain MA, Lin F, van Lierop B, Robinson AJ, Wade JD.
    Peptides; 2010 Sep; 31(9):1730-6. PubMed ID: 20570702
    [Abstract] [Full Text] [Related]

  • 4. Effect of helix-promoting strategies on the biological activity of novel analogues of the B-chain of INSL3.
    Shabanpoor F, Hughes RA, Zhang S, Bathgate RA, Layfield S, Hossain MA, Tregear GW, Separovic F, Wade JD.
    Amino Acids; 2010 Jan; 38(1):121-31. PubMed ID: 19067106
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Chemical synthesis and biological activity of rat INSL3.
    Smith KJ, Wade JD, Claasz AA, Otvos L, Temelcos C, Kubota Y, Hutson JM, Tregear GW, Bathgate RA.
    J Pept Sci; 2001 Sep; 7(9):495-501. PubMed ID: 11587188
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Defining the LGR8 residues involved in binding insulin-like peptide 3.
    Scott DJ, Wilkinson TN, Zhang S, Ferraro T, Wade JD, Tregear GW, Bathgate RA.
    Mol Endocrinol; 2007 Jul; 21(7):1699-712. PubMed ID: 17473281
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthetic human insulin 4 does not activate the G-protein-coupled receptors LGR7 or LGR8.
    Lin F, Otvos L, Kumagai J, Tregear GW, Bathgate RA, Wade JD.
    J Pept Sci; 2004 May; 10(5):257-64. PubMed ID: 15160837
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synthesis, conformation, receptor binding and biological activities of monobiotinylated human insulin-like peptide 3.
    Fu P, Layfield S, Ferraro T, Tomiyama H, Hutson J, Otvos L, Tregear GW, Bathgate RA, Wade JD.
    J Pept Res; 2004 Feb; 63(2):91-8. PubMed ID: 15009530
    [Abstract] [Full Text] [Related]

  • 18. Characterization of the rat INSL3 receptor.
    Scott DJ, Fu P, Shen PJ, Gundlach A, Layfield S, Riesewijk A, Tomiyama H, Hutson JM, Tregear GW, Bathgate RA.
    Ann N Y Acad Sci; 2005 May; 1041():13-6. PubMed ID: 15956681
    [Abstract] [Full Text] [Related]

  • 19. Relaxin research in the postgenomic era.
    Kawamura K, Sudo S, Kumagai J, Pisarska M, Hsu SY, Bathgate R, Wade J, Hsueh AJ.
    Ann N Y Acad Sci; 2005 May; 1041():1-7. PubMed ID: 15956679
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 29.